Generelt viste data, at behandling med Zavesca kan reducere progressionen af klinisk relevante neurologiske symptomer hos patienter med Niemann- Picks sygdom, type C.
Overall the data show that treatment with Zavesca can reduce the progression of clinically relevant neurological symptoms in patients with Niemann-Pick type C disease.